Investor profile
Jacques Mizrahi
Corporate VC, Venture capital & Venture Partner Bioqube at Bioqube Ventures, Executive Leader, Cardiovascular & Metabolic Diseases at Roche
Jacques Mizrahi is an Executive Leader, Cardiovascular & Metabolic Diseases at Roche, whose known portfolio counts 14 companies.
Is Jacques Mizrahi a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Sector
- AIHealthcare
Contacts
Affiliated funds' portfolios
Venture Partner Bioqube at Bioqube Ventures, whose known portfolio counts 8 companies
- Actithera
- Bicara Therapeutics
- Primmune Therapeutics
- CatalYm
- Anavo Therapeutics
- Commit Biologics
- Spica Therapeutics
- SynOx Therapeutics
Executive Leader, Cardiovascular & Metabolic Diseases at Roche, whose known portfolio counts 14 companies
- Freenome
- C4 Therapeutics
- Splice Bio
- GlycoEra
- Flatiron Health
- MISSION Therapeutics
- NMD Pharma
- Cour Pharmaceuticals Development
- Proacta
- Affimed
- DiogenX
- Mironid
- and 2 more
Investor Profile
The listing covers sectors AI and Healthcare, and focus areas Biotech, Data Analytics, Diagnostics and Digital Health. Startups operating in these areas may find Jacques Mizrahi relevant.
Stage-wise, the deals at Roche cluster around Growth, Late-Stage and Pre-Seed rounds.
What the affiliated firm has backed is the closest available signal on whether Jacques Mizrahi is worth approaching.
Colleagues
David Krummenacher
Investor
Lucerne, Switzerland
Deborah Weyih
Investor
Rodersdorf, Switzerland
Alexander Demoulin
Principal
Belgium
Ouali Omani
Global Commercialisation Strategy Leader
Basel, Switzerland
Muriel Badawi
Affiliated
Paris, France
David Evans
Senior Investment Director
Basel, Switzerland
Ursula Erasmus
Investor
Canada
Dirk Reyn
Managing Partner
Vosselaar, Belgium
Nico Vandervelpen
Co-founder and Managing Partner
Limburg, Belgium
Cedric Mauchien
Investor
Zürich, Switzerland
Carole Nuechterlein
Investor
Basel, Switzerland
Debora Dumont
Co-founder and Managing Partner
Limburg, Belgium
Tol Trimborn
Investor
Netherlands
Frequently asked questions
Who is Jacques Mizrahi?
Jacques Mizrahi is a corporate venture investor and venture capital investor based in Basel, Switzerland, listed as Executive Leader, Cardiovascular & Metabolic Diseases at Roche. The known portfolio of that firm counts 14 companies. That portfolio belongs to the firm, not to Jacques Mizrahi personally.
What does Jacques Mizrahi invest in?
Listed sectors include AI and Healthcare; listed focus areas include Biotech, Data Analytics, Diagnostics and Digital Health. Those tags come from the portfolios of the firms this profile is attached to, so they read as a record of what has been backed rather than a stated preference for what comes next.
What stage does Jacques Mizrahi invest at?
Roche appears in Growth, Late-Stage and Pre-Seed rounds across its known deals, and Jacques Mizrahi is listed there as Executive Leader, Cardiovascular & Metabolic Diseases. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.
Which firm is Jacques Mizrahi listed at?
Jacques Mizrahi is listed as Executive Leader, Cardiovascular & Metabolic Diseases at Roche. 13 other people in the database share a firm with Jacques Mizrahi.
How do I contact Jacques Mizrahi?
A LinkedIn page is on file for Jacques Mizrahi. It is readable inside RaiseHunt after you create an account. The database holds no email address and no phone number for this profile.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal